Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study

Autor: Ray, Kausik K., Bruckert, Eric, Peronne-Filardi, Pasquale, Ebenbichler, Christoph, Vogt, Anja, Bridges, Ian, Sibartie, Mahendra, Dhalwani, Nafeesa
Zdroj: In Atherosclerosis February 2023 366:14-21
Databáze: ScienceDirect